| Literature DB >> 33167519 |
Sylwia Nakonieczna1, Aneta Grabarska2, Wirginia Kukula-Koch1.
Abstract
Gastric cancer belongs to the heterogeneous malignancies and, according to the World Health Organization, it is the fifth most commonly diagnosed cancer in men. The aim of this review is to provide an overview on the role of natural products of plant origin in the therapy of gastric cancer and to present the potentially active metabolites which can be used in the natural therapeutical strategies as the support to the conventional treatment. Many of the naturally spread secondary metabolites have been proved to exhibit chemopreventive properties when tested on the cell lines or in vivo. This manuscript aims to discuss the pharmacological significance of both the total extracts and the single isolated metabolites in the stomach cancer prevention and to focus on their mechanisms of action. A wide variety of plant-derived anticancer metabolites from different groups presented in the manuscript that include polyphenols, terpenes, alkaloids, or sulphur-containing compounds, underlines the multidirectional nature of natural products.Entities:
Keywords: gastric cancer; natural medicine; phytocompounds; phytotherapy
Year: 2020 PMID: 33167519 PMCID: PMC7663924 DOI: 10.3390/ijms21218307
Source DB: PubMed Journal: Int J Mol Sci ISSN: 1422-0067 Impact factor: 5.923
The identity of the described plant species with their anticancer properties against the gastric cancer.
| Plant Species | Active Compound | Cell Line | Bioactive Effect | Ref. |
|---|---|---|---|---|
|
| Cordicepine | SGC-7901 | 1. Antiproliferative effects cell cycle arrest at S phase targeting PI3K/Akt pathway ↑ cellular stress ↑ caspase-3 and PARP cleavage ↓ survivin expression ↑ epithelial markers expression ↓ mesenchymal markers expression | [ |
|
| Allicin | SGC-7901 | 1. Antiproliferative effects cell cycle growth at G2/M phase ↓ telomerase activity ↑ caspase-3 cleavage ↑ Bax/Bcl-2 ratio targeting p38/MAPK pathway | [ |
|
| Epigallocatechin gallate | SGC-7901 | 1. Antiproliferative effects ↓ EGFR and IGF-1R targeting Wnt/β-catenin pathway ↓ HDAC and DNMT expression ↓ ROS generation ↑ caspase-3 and PARP cleavage ↓ VEGF expression ↑ ROS generation ↓ VEGF expression | [ |
| Synthesized gold nanoparticles | AGS | 1. Proapoptotic effects ↑ ROS generation ↑ Bax and caspase-3 expression ↓ Bcl-xl/Bcl-2 expression | [ | |
|
| Plumbagin | AGS | 1. Proapoptotic effects ↓ Akt and STAT targeting NF-κB pathway ↓ IAP1/XIAP expression ↓ Bcl2/Bcl-xl expression ↓ NF-κB pathway ↓ VEGF expression | [ |
| TTF and DTFG | SGC-7901 |
↑ apoptosis ↓ cell cycle | [ | |
|
| Costunolide | SGC-7901 | 1. Antiproliferative effects cell cycle arrest at G2/M phase ↑ p53 and p21 expression ↓ cyclin B1 ↑ caspase -3 and PARP cleavage ↑ Bax and Bak expression ↓ Bcl-2 expression ↓ VEGF expression | [ |
|
| Thymoquinone | BGC-823 | 1. Antimetastatic effects ↓ PI3K/Akt pathway ↑ epithelial markers expression ↓ mesenchymal markers expression ↓ JAK/STAT pathway ↓ VEGF expression ↓ JAK/STAT pathway ↓ cyclin D1, Bcl-2, survivin | [ |
|
| Diterpenoids | SGC-7901/ADR | 1. Antiproliferative effects cell cycle arrest at G2/M phase ↑ caspase-3 cleavage ↑ Bax expression ↓ Bcl-2 expression | [ |
| Total extract | SGC-7901 | 1. Proapoptotic effects caspases expression ↑ Bax expression ↓ Bcl-2 expression | [ | |
| Diosbulbine B | SGC-7901 |
↓ cell proliferation | [ | |
|
| Berberine | BGC-823 | 1. Antiproliferative effects ↓ c-myc cell cycle arrest at G0/G1 phase ↓ cyclin D1 and HNF4α ↓ ERK/JNK/p38 MAPK pathway ↓ PI3K/Akt pathway PARP and caspase-3 cleavage ↑ caspases expression ↓ Bax/Bcl-2 ratio targeting p38/JNK MAPK pathway targeting NF-κB pathway ↓ MMP-3 | [ |
|
| Tetrandrine | HGC-27 | 1. Proapoptotic effects ↑ Bax/Bcl-2 ratio ↑ caspase-3 cleavage ↑ Apaf-1 ↑ LC3II and Beclin-1 expression ↓ PI3K/Akt/mTOR pathway | [ |
|
| Piperlongumine | SGC-7901 | 1. Antiproliferative effects ↓ TrxR1 ↑ GADD45α ↓ cyclin B1 and Cdc2 expression cell cycle arrest at G2/M phase ↓ JAK/STAT pathway ↑ ROS generation ↑ p38/JNK pathway ↑ caspase-3 and PARP cleavage ↑ BIM expression ↓ JAK/STAT pathway ↓ MMP-9 and Twist | [ |
| Matrine | BGC-823 | 1. Antiproliferative effects cell cycle arrest at G1 and G2/M phases ↓ PI3K/Akt pathway ↓ uPA ↓ miR-93-5p expression ↑ AHNAK expression ↑ Fas/FasL expression | [ |
Figure 1The molecular effects of natural products in gastric cancer cells.
The chemical structures of the single active components of the extracts characterized by the inhibitory activity against stomach cancer, described in the review.
| Plant | Bioactive Compound | Molecular Formula | Structure |
|---|---|---|---|
|
| Allicin | C6H10OS2 |
|
|
| Berberine | C20H18NO4+ |
|
| Epiberberine | C20H18NO4 |
| |
|
| Cordycepin | C10H13N5O3 |
|
|
| Diosbulbin B | C19H20O6 |
|
|
| Thymoquinone | C10H12O2 |
|
|
| Piperlongumine | C17H19NO5 |
|
|
| Plumbagin | C11H8O3 |
|
|
| Costunolide | C15H20O2 |
|
| Matrine | C15H24N2O |
| |
| Oxymatrine | C15H24N2O2 |
| |
|
| Tetrandrine | C38H42N2O6 |
|
The examples of in vivo studies on the activity of natural products against gastric cancer in xenograft mice.
| Natural Product | Plant of Origin | Model | Mechanism of Action | Molecular Mechanism | References |
|---|---|---|---|---|---|
| Baicalein | Nude mice | Reduced tumor volume | Induced apoptosis, | [ | |
| Chaetocin | Nude mice | Inhibited proliferation, induced cell cycle arrest (G2/M) and apoptosis | Inactivation of PI3K/AKT pathway | [ | |
| Cucurbitacin C | Female and male nude mice | Reduced tumor volume | Inhibition of STAT3 | [ | |
| 3,3′-diindolylmethane | Cruciferous plants | female nude mice | Inhibited tumor growth | Increase of LC3 levels (microtubule-associated protein light chain) | [ |
| Dioscin | Nude mice | Induced apoptosis, cell arrest (S phase), inhibited tumor growth | Induced ROS generation and Ca2+ release | [ | |
| Formononetin-coumarin hybrid | Nude mice | Inhibited tumor growth | Inhibition of SIRT-1, Wnt/β-Catenin and AKT/mTOR pathways | [ | |
| Nitidine chloride |
| Male BALB/cA nude mice | Reduced tumor volume | Decreased STAT3 and VEGF | [ |
| Perillaldehyde |
| Female BALB/c nude mice | Inhibited tumor growth | Increased caspase-3, p53, catepsin and LC3-II | [ |
| S-allylmercaptocysteine | Garlic | Female BALB/e nude mice | Inhibited tumor growth | - | [ |
| 6-shogaol |
| Athymic nude mice | Inhibited tumor growth | [ |
The examples of clinical studies on the activity of natural products against gastric cancer in humans.
| Natural Product/Extract | Study Group | Dosage | Comments | Reference | |
|---|---|---|---|---|---|
| Gastric cancer | Garlic extract and oil | 3365 residents with high risk of gastric cancer | 200 mg aged garlic extract and 1 mg steam distilled garlic oil for 7 years | Garlic supplementation was associated with a significantly reduced risk of incidence of gastric cancer and death | [ |
| An 82-year old woman | 900 mg of extract for 5 months | Marked decrease in the polyploidy mass of the tumor and decreased lesion of the prepyloric antrum | [ | ||
| 1329 patients (51–68 years old) | Injection: 40–80 mL/dose, 7–21 doses/session | Adjuvant therapy with anticancer treatment (typically folinic acid + fluorouracil + oxaliplatin) improved the response to chemotherapy and reduced thrombocytopenia, anemia, nausea, peripheral neurotoxicity and hepatic injury | [ | ||
| Curcumin from | 25 patients | 500 mg/ day, 3 months | Histologic improvement of lesions | [ | |
| 240 patients (58–79 years old) | 10 mL/ thrice daily orally (300 g of leaves in 500 g of honey in 40 mL of 40% alcohol) 6 days before and during chemotherapy | Adjuvant therapy of metastatic solid tumor with 5-florouracil. Increased tumor regression | [ |